Delivery Order SPE2DR25D2206-SPE2DR26F9GF3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $7,226.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among eligible...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $4,335.64. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by December 11, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $3,977.47. This contract represents a firm fixed-price delivery order under a competitive, non-set-aside procurement and is scheduled for completion by July 25, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office and serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a contract value of $7,837.15. This is a firm fixed-price delivery order with no set-aside designation, issued under the competitive contracting process. The ultimate completion date is December 5, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $9,120.04 on December 16, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units). This firm fixed-price delivery order, with an ultimate completion date of December 17, 2025, represents a non-set-aside competitive award fulfilling pharmaceutical supply needs for federal medical procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $62,269.36. This competitively awarded, firm fixed-price delivery order is not subject to any set-aside designation and is scheduled for ultimate completion by December 3, 2025. The vendor will perform from its corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Myrbetriq ER 50 mg tablets (30-count packages) with a contract value of $9,750.53. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract has an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count units) with a ceiling value of $49,705.07. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for ultimate completion by November 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $2,524.00. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's larger pharmaceutical supply framework. The order is scheduled for completion by December 1, 2025, and will be fulfilled from AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a contract ceiling value of $10,553.53. This is a firm fixed-price delivery order with an ultimate completion date of November 12, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9GF3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $13,043.19. This firm fixed-price delivery order, with an ultimate completion date of December 18, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle supports comprehensive global pharmaceutical supply operations for military healthcare programs, enabling the company to deliver a broad range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen's substantial federal contract portfolio demonstrates its critical role in supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible and competitively awarded contract arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.0k | 12/16/25 |